|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 7288 Hanover Green Drive |
Address2 |
|
City | Mechanicsville |
State | VA |
Zip Code | 23111 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 401104368-12
|
||||||||
|
6. House ID# 435580001
|
TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Justin Goodman |
Date | 1/20/2023 8:35:57 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
H.R.1905 - Alternatives to Animals for Regulatory Freedom (AARF) Act- To allow drug makers to use alternatives to animal testing to fulfill FDA requirements.
S.1378 - Animal Freedom from Testing, Experiments, and Research Act of 2021- To require federal labs to allow animals to be retired when experiments end.
H.R.5244 - Animal Freedom from Testing, Experiments, and Research Act of 2021- To require federal labs to allow animals to be retired when experiments end.
H.R.5527 - Accountability in Foreign Animal Research Act- To prohibit funding for animal experiments in certain foreign countries.
H.R.6186 - Preventing Animal Abuse and Waste (PAAW) Act of 2021- To prohibit funding for certain dog experiments.
H.R.8699 - Protecting Dogs Subjected to Experiments Act- - To prohibit funding for certain dog experiments.
Issues related to oversight of and taxpayer funding for animal testing (no specific legislation)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Justin |
Goodman |
|
|
|
Tristan |
Daedalus |
|
Deputy Communications Director/Legislative Aide - Rep. Ann Marie Buerkle (1/11-11/11)
Communications Director - Rep. Matt Salmon (6/14-1/17), Rep. Raul Labrador (3/17)
Communications Director and Policy Advisor - Rep. Pat Fallon (1/21-4/21) |
|
Desiree |
Bender |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R.8239 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2023- Funding and oversight of taxpayer-funded animal experiments
H.R.8256 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2023- Funding and oversight of taxpayer-funded animal experiments
H.R.8236 - Department of Defense Appropriations Act, 2023- Funding and oversight of taxpayer-funded animal experiments
H.R.8262 - Department of the Interior, Environment, and Related Agencies Appropriations Act, 2023- Funding and oversight of taxpayer-funded animal experiments
H.R.8295 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023- Funding and oversight of taxpayer-funded animal experiments
H.R.8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023- Funding and oversight of taxpayer-funded animal experiments
H.R.8282 - Department of State, Foreign Operations, and Related Programs Appropriations Act, 2023- Funding and oversight of taxpayer-funded animal experiments
H.R. 2617, the Consolidated Appropriations Act, 2023 - Funding and oversight of taxpayer-funded animal experiments
Issues related to oversight of and taxpayer funding for animal testing (no specific legislation)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Justin |
Goodman |
|
|
|
Tristan |
Daedalus |
|
Deputy Communications Director/Legislative Aide - Rep. Ann Marie Buerkle (1/11-11/11) Communications Director - Rep. Matt Salmon (6/14-1/17), Rep. Raul Labrador (3/17) Communications Director and Policy Advisor - Rep. Pat Fallon (1/21-4/21) |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
H.R.591-Defund EcoHealth Alliance Act- Cutting funding for EcoHealth Alliance
H.R.3256 - Defund the Wuhan Institute of Virology Act- Cutting funding for the Wuhan Institute of Virology Act
H.R.834- Pandemics Require Evaluating, Planning, And Responding Effectively (PREPARE) Act- Launching commission to study COVID origins, including Wuhan Institute of Virology lab leak hypothesis
H.R.1937 - Cost Openness and Spending Transparency (COST) Act- Increasing transparency about federal spending
S.760 - Cost Openness and Spending Transparency (COST) Act- Increasing transparency about federal spending
S.1260 - United States Innovation and Competition Act of 2021- Funding and oversight of taxpayer-funded animal experiments
S.2056 - Stop the Outlay of Payments Act- Cutting funding for grantees that violate federal law
H.R.5270 - Pausing Enhanced Pandemic Pathogen Research Act of 2021- Prohibits certain gain-of-function research for 5 years
S.3012 - Viral Gain of Function Research Moratorium Act- Prohibits certain gain-of-function research
S.3159 - Fairness and Accountability in Underwriting Chinese Institutions Act- Prohibits certain gain-of-function research
S.5056 - Defund EcoHealth Alliance Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Justin |
Goodman |
|
|
|
Tristan |
Daedalus |
|
Deputy Communications Director/Legislative Aide - Rep. Ann Marie Buerkle (1/11-11/11)
Communications Director - Rep. Matt Salmon (6/14-1/17), Rep. Raul Labrador (3/17)
Communications Director and Policy Advisor - Rep. Pat Fallon (1/21-4/21) |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |